Before a digoxin dose, confirm the apical pulse, potassium, kidney function, and new meds so you don’t dose into bradycardia or toxicity.
Digoxin can be a steady workhorse for atrial fibrillation rate control and for symptom relief in some heart failure patients. It can also go sideways fast when the patient’s status shifts. A dose that fit yesterday can be unsafe today if the kidneys slow down, potassium drops, or an interacting drug gets added.
This checklist is written for clinicians and medication administrators who already work from signed orders and facility policy. It’s meant to tighten the bedside “safety pass” so the chart, the monitor, and the patient’s symptoms all line up before you give the dose.
Why Digoxin Needs A Real Pre-Dose Check
Digoxin slows conduction through the AV node and can lower the ventricular rate. That’s often the point. But if the patient is already running slow, or if there’s AV block on board, the next dose can push them into symptomatic bradycardia or worse.
Clearance is tied to renal function, so reduced clearance can raise levels across days even when the daily dose hasn’t changed. Electrolytes shift tolerance, too. Low potassium and low magnesium can raise arrhythmia risk during digoxin therapy, while high calcium can increase electrical irritability.
Interactions are the other big trap. Some drugs raise digoxin exposure by affecting transport and clearance. The FDA prescribing label on DailyMed also spells out serum level timing, including drawing a trough or waiting at least 6 hours after a dose.
Checks Before Giving Digoxin At The Bedside
Use the same order each time. A set routine keeps you from chasing one lab while missing a rhythm change. It also makes your documentation cleaner when you do need to hold the dose.
Confirm The Order And Hold Parameters
Verify the medication, dose, route, and schedule against the MAR. Digoxin comes in oral and IV forms, and route changes can shift what “the same dose” means in practice. Confirm the indication in the chart so you know the rate goal you’re aiming for.
Check whether hold parameters are written in the order set. If they’re present, follow them. If they’re missing and the pulse is slow or the rhythm is unstable, pause and escalate for a clear parameter before administration.
Take A Full Minute Apical Pulse
Count the apical pulse for 60 seconds. Short counts miss pauses and underestimate irregularity, especially in atrial fibrillation. Note rate, regularity, and strength, then match that to the patient’s symptoms.
If your facility ties holding digoxin to hypotension or symptoms with bradycardia, pull blood pressure in the same pass. A borderline pulse with new dizziness is a different picture than the same number in a comfortable, asymptomatic patient.
Check Telemetry Or A Rhythm Strip
Scan for new AV block, long pauses, junctional rhythm, or a sudden shift in the ventricular rate trend. If the patient has a pacemaker, verify capture and the programmed lower rate before you assume the rhythm is protected.
Also watch for frequent ectopy or bigeminy. The monitor may count electrical beats that don’t produce a strong peripheral pulse, so pair the strip with the apical count and what the patient feels.
Review Electrolytes That Shift Tolerance
Start with potassium and magnesium. Diuretics, vomiting, diarrhea, poor intake, and insulin shifts can drop potassium quickly. Low potassium or low magnesium can make the myocardium more reactive to digoxin’s effects.
Check calcium as well. When calcium is high, rhythm instability can be more likely during digoxin therapy. If electrolytes are out of range or changing fast, pause and follow your unit’s correction and notification process.
Review Kidney Function And Trend
Digoxin clearance tracks with renal function. Review creatinine, estimated GFR trend, urine output, and any note of acute kidney injury. A rising creatinine across days is a red flag, even if today’s number isn’t dramatic.
If the patient is dehydrated, newly oliguric, or has a new renal diagnosis, flag the dose for review. This is also a good time to verify the current weight if dosing decisions are tied to weight or recent fluid shifts.
Do A Fast Interaction And Symptom Screen
Scan for new starts, stops, or dose changes since the last digoxin administration. Common interaction patterns include amiodarone, verapamil, diltiazem, quinidine, and some macrolide antibiotics, plus stacked AV-node blockers that can drop the pulse.
Ask a tight symptom set: nausea, vomiting, poor appetite, confusion, dizziness, and vision changes like blurred vision or yellow tint. The MedlinePlus digoxin monograph lists side effects and warning symptoms that match what many patients report when toxicity starts.
Serum Digoxin Levels: Timing Matters More Than People Think
If a level is part of the plan, treat timing as part of the result. A draw taken too soon after a dose can reflect distribution, not the level that lines up with tissue effect. That can push teams toward the wrong decision.
Use the label timing as your anchor: per DailyMed, levels are best drawn just before the next scheduled dose or at least 6 hours after the last dose. If a level is on the chart, check the draw time against the last administration time before you treat the number as actionable.
Also match the level to the bedside picture. A “normal” level doesn’t erase classic toxicity symptoms, and a high level means more when paired with bradycardia, new block, or electrolyte problems. When draw timing is unclear, clarify it before you act on the result.
Pre-Dose Digoxin Checklist With Actions
This table is built to compress the decision points you actually use at the bedside. It’s not a substitute for an order set. It’s a quick way to catch the repeat offenders that drive digoxin harm.
| Check | What To Look For | What To Do Before Giving |
|---|---|---|
| Order details | Route, strength, schedule, hold parameters | Match to MAR; clarify missing hold rules |
| Apical pulse (60 sec) | Slow rate, irregular beats, weak beats | Hold per order; escalate if slow or unstable |
| Telemetry trend | New AV block, pauses, junctional rhythm, ectopy | Pause for review if rhythm changed |
| Potassium | Low or rapidly falling K+ | Correct per protocol before dosing when ordered |
| Magnesium | Low Mg or recent replacement need | Replace per protocol; recheck plan if unstable |
| Calcium | High calcium or rising trend | Pause and request plan review |
| Kidney function | Rising creatinine, low urine output, AKI | Flag for dose review; watch accumulation risk |
| Serum digoxin level | Draw timing and trend vs prior levels | Use trough/≥6-hour timing for interpretation |
| Medication changes | New antiarrhythmic, antibiotic, AV-node blocker | Notify team; expect plan change or monitoring |
| Symptoms | GI upset, confusion, visual changes, palpitations | Hold and report when symptoms fit toxicity |
Medication Interactions That Deserve A Second Scan
Interaction lists can feel endless, so use a pattern scan. First, check for drugs that can raise digoxin exposure. Next, check for drugs that slow the heart on their own. Both patterns can create trouble even when the ordered digoxin dose hasn’t changed.
The NHS interaction page for digoxin is a practical reference when you’re reconciling a long med list. It’s also useful when a patient mentions a new supplement that isn’t in the chart yet.
Also watch the “stacking” effect. Beta blockers and non-DHP calcium channel blockers can slow the pulse. Combined with digoxin, bradycardia can show up even at modest serum levels, so match the med list to the rate goal and the patient’s symptoms.
Signs That Point Toward Digoxin Toxicity
Toxicity can show up as GI symptoms, neurologic changes, vision changes, or rhythm shifts. Some patients describe vague “off” feelings, so a focused symptom screen helps turn vague into actionable. When symptoms line up with bradycardia, new block, or electrolyte shifts, treat it as a stop sign.
Use the table below as a rapid bedside map. It’s built to help you link a symptom or rhythm clue to the next step you’d take inside your unit workflow.
| Clue | What It Can Mean | Next Step |
|---|---|---|
| Nausea, vomiting, poor appetite | Early toxicity pattern | Hold dose and report; check electrolytes and level timing |
| New confusion or unusual drowsiness | CNS effect, often in older adults | Vitals, rhythm check, medication-change scan |
| Blurred or yellow-tinted vision | Visual disturbance linked to digoxin | Hold and escalate; request level per protocol |
| Bradycardia or new AV block | Excess conduction slowing | Stop dose; obtain ECG review per policy |
| Frequent ectopy or new wide complexes | Ventricular irritability | Close monitoring; escalate per rapid response criteria |
| Palpitations or “skipping” beats | Rhythm instability | Strip review; hold until plan is confirmed |
| Faint feeling or sudden weakness | Low perfusion from slow rate | Vitals, fall precautions, prompt escalation |
What To Do When A Check Fails
When a pre-dose check throws a red flag, the safest move is to pause and make the finding visible. Capture what you found: apical rate and method, rhythm note, symptom report, and the electrolyte and renal snapshot. Then notify through your unit workflow.
Avoid “solo fixes.” Electrolyte replacement, repeat levels, and dose holds work best when they’re tied to a clear plan that matches the indication and the current rhythm goal. If you’re holding due to bradycardia or new block, the plan may also include reevaluating other AV-node blockers on the MAR.
After Giving Digoxin: Monitoring And Documentation
After administration, keep an eye on the heart rate trend and the patient’s symptoms, especially after a new dose, a route change, or a new interacting medication. If the patient reports new nausea, visual changes, dizziness, or confusion after a dose, treat it as actionable data and escalate per policy.
Charting should tell a clean story. If you gave the dose, document the apical pulse method and duration, the rhythm observation, and the lab values you used. If you held the dose, document the trigger and the notification route used, plus any updated instructions.
If patient teaching is part of your role, keep it plain and short. Ask them to report nausea, vision changes, new dizziness, or a suddenly slow pulse. The Mayo Clinic digoxin page summarizes precautions and side effects that can help shape patient-friendly wording.
References & Sources
- DailyMed (NLM/NIH).“Digoxin Tablets: Prescribing Information.”Label guidance on monitoring, interactions, and serum level timing (trough or at least 6 hours after a dose).
- MedlinePlus (NLM/NIH).“Digoxin.”Side effects and warning symptoms used to shape the bedside symptom screen.
- NHS (UK).“Taking Digoxin With Other Medicines And Herbal Supplements.”Interaction list used for the medication-change scan.
- Mayo Clinic.“Digoxin (Oral Route).”Precautions and adverse effects used to guide monitoring and patient teaching language.
Mo Maruf
I created WellFizz to bridge the gap between vague wellness advice and actionable solutions. My mission is simple: to decode the research and give you practical tools you can actually use.
Beyond the data, I am a passionate traveler. I believe that stepping away from the screen to explore new environments is essential for mental clarity and physical vitality.